n(g),n(g')-dimethyl-l-arginine has been researched along with Syndrome in 5 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested the hypothesis that asymmetric dimethylarginine (ADMA) levels could be elevated and influence endothelin-1 and nitric oxide release and action in patients with cardiac syndrome X (CSX)." | 9.10 | Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. ( Chierchia, S; Fermo, I; Fragasso, G; Galluccio, E; Lucotti, P; Margonato, A; Monti, LD; Paroni, R; Piatti, P; Pozza, G; Setola, E, 2003) |
| "To examine the prognostic value of serum levels of asymmetric dimethylarginine (ADMA) in patients with stable coronary heart disease (CHD) thus explore a potential biomarker of "toxin syndrome" in CHD." | 7.91 | Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease. ( Chen, KJ; Chen, Z; Gao, ZY; Shang, QH; Shi, DZ; Xu, H; Yu, CA, 2019) |
| "We tested the hypothesis that asymmetric dimethylarginine (ADMA) levels could be elevated and influence endothelin-1 and nitric oxide release and action in patients with cardiac syndrome X (CSX)." | 5.10 | Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. ( Chierchia, S; Fermo, I; Fragasso, G; Galluccio, E; Lucotti, P; Margonato, A; Monti, LD; Paroni, R; Piatti, P; Pozza, G; Setola, E, 2003) |
| " Here, we summarize some molecular mechanisms leading from hyperhomocysteinemia, elevated asymmetric dimethylarginine (ADMA) and advanced glycation end products (AGEs)-modified proteins to atherogenic endothelial phenotype and offer a model of endothelial dysfunction based on the interconnectedness of diverse functions." | 4.82 | Endothelial cell dysfunction: the syndrome in making. ( Brodsky, SV; Chen, J; Goligorsky, MS; Li, H; O'Riordan, E; Smirnova, I, 2005) |
| "To examine the prognostic value of serum levels of asymmetric dimethylarginine (ADMA) in patients with stable coronary heart disease (CHD) thus explore a potential biomarker of "toxin syndrome" in CHD." | 3.91 | Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease. ( Chen, KJ; Chen, Z; Gao, ZY; Shang, QH; Shi, DZ; Xu, H; Yu, CA, 2019) |
| " Abnormalities in coronary microvascular function result from increased microvascular resistances and impaired endothelial release of vasoactive substances, especially in production and bioavailability of endothelium derived NO." | 2.47 | Peripheral hemorheological and vascular correlates of coronary blood flow. ( Damaske, A; Fasola, F; Fineschi, M; Forconi, S; Gori, T; Jabs, A; Munzel, T; Muxel, S; Orphal, D; Parker, JD; Radmacher, MC; Schaefer, S; Wild, P, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, H | 1 |
| Chen, Z | 1 |
| Shang, QH | 1 |
| Gao, ZY | 1 |
| Yu, CA | 1 |
| Shi, DZ | 1 |
| Chen, KJ | 1 |
| Damaske, A | 1 |
| Muxel, S | 1 |
| Fasola, F | 1 |
| Radmacher, MC | 1 |
| Schaefer, S | 1 |
| Jabs, A | 1 |
| Orphal, D | 1 |
| Wild, P | 1 |
| Parker, JD | 1 |
| Fineschi, M | 1 |
| Munzel, T | 1 |
| Forconi, S | 1 |
| Gori, T | 1 |
| Piatti, P | 1 |
| Fragasso, G | 1 |
| Monti, LD | 1 |
| Setola, E | 1 |
| Lucotti, P | 1 |
| Fermo, I | 1 |
| Paroni, R | 1 |
| Galluccio, E | 1 |
| Pozza, G | 1 |
| Chierchia, S | 1 |
| Margonato, A | 1 |
| O'Riordan, E | 1 |
| Chen, J | 1 |
| Brodsky, SV | 1 |
| Smirnova, I | 1 |
| Li, H | 1 |
| Goligorsky, MS | 1 |
| Wieczorek-Surdacka, E | 1 |
| Surdacki, A | 1 |
| Bode-Böger, SM | 1 |
| Schubert, B | 1 |
| Sulowicz, W | 1 |
2 reviews available for n(g),n(g')-dimethyl-l-arginine and Syndrome
| Article | Year |
|---|---|
Peripheral hemorheological and vascular correlates of coronary blood flow.
Topics: Arginine; Blood Flow Velocity; Chest Pain; Coronary Circulation; Diagnosis, Differential; Endotheliu | 2011 |
Endothelial cell dysfunction: the syndrome in making.
Topics: Animals; Apoptosis; Arginine; Cardiovascular Diseases; Cellular Senescence; Endothelium, Vascular; G | 2005 |
1 trial available for n(g),n(g')-dimethyl-l-arginine and Syndrome
| Article | Year |
|---|---|
Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels.
Topics: Angina Pectoris; Arginine; Blood Pressure; Coronary Angiography; Cyclic GMP; Endothelin-1; Endotheli | 2003 |
2 other studies available for n(g),n(g')-dimethyl-l-arginine and Syndrome
| Article | Year |
|---|---|
Asymmetric Dimethylarginine Predicts One-year Recurrent Cardiovascular Events: Potential Biomarker of "Toxin Syndrome" in Coronary Heart Disease.
Topics: Arginine; Biomarkers; Coronary Disease; Humans; Odds Ratio; Recurrence; Risk Factors; ROC Curve; Syn | 2019 |
Elevated plasma asymmetric dimethyl-L-arginine in a patient with Gordon syndrome.
Topics: Arginine; Diagnosis, Differential; Electrolytes; Female; Humans; Hyperkalemia; Hypertension; Middle | 2007 |